Jason Haddock has an estimated net worth of $3.76 Million. This is based on reported shares across multiple companies, which include Codiak BioSciences, Inc., ARRAY BIOPHARMA INC, and Merus N.V..
2018 was Jason Haddock's most active year for acquiring shares with 5 total transactions. Jason Haddock's most active month to acquire stocks was the month of November. 2019 was Jason Haddock's most active year for disposing of shares, totalling 9 transactions. Jason Haddock's most active month to dispose stocks was the month of June. 2019 saw Jason Haddock paying a total of $320,450.00 for 85,000 shares, this is the most they've acquired in one year. In 2019 Jason Haddock cashed out on 1,103,049 shares for a total of $3,551,373.00, their largest year based on trade value.